USPTO serial 99575365
CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Deadline: 1 Aug 2026
The USPTO has refused the mark because it describes your services, rejected the Class 9 specimen as mere advertising, and requires a physical domicile address along with clarifications for the service descriptions.
PHARMANEST INC
Princeton, NJ, US
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable cloud-based software for detecting and analyzing fibrosis and other fibrillar protein histological phenotypes for scientific use; Downloadable cloud-based software for scientific research, namely, for collecting, processing, and visualizing histological features and phenotypes of fibrosis and other fibrillar proteins in connection with scientific or medical research; Downloadable cloud-based software for analyzing spatially resolved tissue-based datasets; Downloadable cloud-based software for analyzing spatially resolved datasets, in particular analyzing spatially resolved single-fiber datasets and spatially resolved single-cell datasets, individually or in conjunction; Downloadable cloud-based software for visualizing spatially resolved single-fiber datasets and spatially resolved single-cell datasets and their phenotypic clusters, individually or in conjunction; Downloadable cloud-based software for analyzing, measuring and quantifying phenotypes of fibrosis or other fibrillar proteins in images using advanced computational and clustering techniques | ACTIVE | May 1, 2025 |
| 042 | Cloud computing featuring software for use in the fields of artificial intelligence; Cloud computing featuring software for use in the fields of biosciences, in particular pathology, histology, histopathology, spatial biology, cytopathology, biology, botany, pharmacology, medical, veterinary; Cloud computing featuring software for use in archiving, viewing and annotating digitized images of microscope slides; Cloud computing featuring software for use in providing digital pathology services, in particular web-based digital pathology services; Cloud computing featuring software for use in analyzing, measuring and quantifying the phenotypic traits of fibrosis or other fibrillar proteins in images using advanced computational and clustering techniques; Cloud computing featuring software for use in analyzing spatially resolved datasets, in particular analyzing spatially resolved single-fiber datasets and spatially resolved single-cell datasets, individually or in conjunction; Cloud computing featuring software for use in visualizing spatially resolved single-fiber datasets and spatially resolved single-cell datasets and their phenotypic clusters, individually or in conjunction; Cloud computing featuring software for use in associating information with digitized images of microscope slides, in particular pathological data, clinical data, clinical history data, research data, reference data, analysis data, statistical data; Cloud computing featuring software for use in quantifying phenotypes of fibrosis; Cloud computing featuring software for use in discovering novel biomarkers of fibrosis | ACTIVE | May 1, 2025 |
| Date | Code | Event |
|---|---|---|
| Jul 1, 2026 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Jul 1, 2026 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| May 1, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| May 1, 2026 | GNRT | NON-FINAL ACTION E-MAILED |
| May 1, 2026 | CNRT | NON-FINAL ACTION WRITTEN |
| May 1, 2026 | DOCK | ASSIGNED TO EXAMINER |
| Apr 21, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jan 2, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED |
| Jan 2, 2026 | NWAP | NEW APPLICATION ENTERED |